Diazyme Laboratories Competitors and Similar CompaniesClear all

Diazyme Laboratories's competitors and similar companies include KalVista Pharmaceuticals, Oncquest Laboratories, PreventAGE Health Care and Intelligent Bio Solutions.

	Diazyme Laboratories Diazyme Laboratories is a company that specializes in the research and development, manufacture, and distribution of diagnostic reagents.	KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).	Oncquest Laboratories Oncquest is a pathology laboratory.	PreventAGE Health Care PreventAGE Health Care is a company providing patients and doctors with the tools to predict and manage diabetic complications.	Intelligent Bio Solutions GBS (formerly known as Glucose Biosensor Systems (Greater China) Holdings) is a biosensor diagnostic technology company.
Founding Date	Founding Date 2000	Founding Date 2011	Founding Date 2003	Founding Date 2012	Founding Date N/A
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech diabetes drug development ecommerce medical diagnostics	Tags Healthcare biotech diabetes medical diagnostics	Tags Healthcare diabetes medical diagnostics oncology	Tags Healthcare biotech diabetes medical diagnostics	Tags Healthcare biotech diabetes medical diagnostics
Locations	Locations Poway, US HQ Shanghai, CN Dresden, DE	Locations Porton Down, GB HQ Cambridge, US	Locations New Delhi, IN HQ	Locations Lebanon, US HQ	Locations New York, US HQ Barangaroo, AU
Employees	Employees 901% increase	Employees 150	Employees 746	Employees 8	Employees 1623% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 523.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 7 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $49.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3.1m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $3.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.8m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $46m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $1.2m (FY, 2025)
Net income	Net income N/A	Net income ($109.5m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($10.6m) (FY, 2025)